Finch Therapeutics Group

Finch Therapeutics Group

Finch Therapeutics Group

Finch Therapeutics is unlocking the therapeutic potential of the microbiome through our humanfirst discovery platform.
Type
B2c
Founded
2017
Raised
$162M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$90,000,000
Venture capital (Series D) - 2020
SIG Shumway Capital Trans-Pacific Technology Fund (TPTF) +8
$36,000,000
Venture capital (Series B) - 2018
Shumway Capital Morgan Noble Avenir Growth Capital +1
Team Size
50+
Employees
$90,000,000 Venture capital (Series D)
FinSMEs

Finch Therapeutics Raises $90M in Series D Financing

$36,000,000 Venture capital (Series B)
FinSMEs , Venture Funding News

Finch Therapeutics Group Raises $36M in Series B Financing

Health Funding Science